AG
AXNX

Advisor Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Advisor Group’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$27K Buy
940
+840
+840% +$20K ﹤0.01% 3809
2019
Q3 		$3K Sell
100
-300
-75% -$10.5K ﹤0.01% 4890
2019
Q2 		$16K Sell
400
-100
-20% -$2.81K ﹤0.01% 4123
2019
Q1 		$12K Buy
+500
New +$9.07K ﹤0.01% 4291

Other funds holding AXNX

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Advisor Group's AXNX Position: Q4 2019 in Review

Advisor Group increased its Axonics, Inc. Common Stock (AXNX) stake by 840% in Q4 2019, buying an estimated $20K and bringing the position to 940 shares worth $27K. The position accounts for ﹤0.01% of the portfolio, ranked #3809.

Advisor Group first reported a position in AXNX in Q1 2019 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold AXNX as of Q4 2019.

  • Advisor Group held 940 shares of Axonics, Inc. Common Stock worth $27K as of Q4 2019.
  • Advisor Group bought 840 Axonics, Inc. Common Stock shares in Q4 2019, an estimated $20K.
  • Axonics, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3809 holding.
  • Advisor Group first reported a position in Axonics, Inc. Common Stock in Q1 2019 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.